Quick Answer
XBiotech Inc. reported Research And Development Expense of $47.39 million for the year ending 2025.
- XBiotech Inc. showed an increase of +25.5% in Research And Development Expense from 2024 to 2025.
- This data is from XBiotech Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), XBiotech Inc.'s Research And Development Expense has grown by 497.2%.
- Historical annual values: Fiscal year 2025: $47.39 million | Fiscal year 2024: $37.76 million | Fiscal year 2023: $32.85 million | Fiscal year 2022: $31.54 million | Fiscal year 2021: $28.27 million | Fiscal year 2020: $9.53 million | Fiscal year 2019: $24.09 million | Fiscal year 2018: $15.73 million | Fiscal year 2017: $26.42 million | Fiscal year 2016: $42.49 million | Fiscal year 2015: $31.31 million | Fiscal year 2014: $14.33 million | Fiscal year 2013: $7.94 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: